S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SUPN Supernus Pharmaceuticals Inc

35.60

0.01 (0.03%)

Dec 24 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/07/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Jack A. Khattar

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Supernus Pharmaceuticals Charts.

Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Supernus Pharmaceuticals Charts.

Supernus Pharmaceuticals Inc News

Form 8-K - Current report
Friday 20 December 2024 (5 days ago) • Edgar (US Regulatory)

Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (viloxazine) in Canada
Monday 16 December 2024 (1 week ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 4 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference
Tuesday 26 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference
Wednesday 13 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

More Supernus Pharmaceuticals Inc News Articles

ELine Entertainment (CE)

Hallmark Venture (PK)

KULR Technology

Asia Broadband (PK)

Virexit Technologies (PK)

Intergrated Cannabis Sol... (PK)

Cann American (CE)

Impact Fusion (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions